Board of Directors & Committees

Dr. Nemire is the Dean of Larkin University College of Pharmacy and a graduate of Ohio Northern University and the University of Toledo Colleges of Pharmacy. She completed formal fellowship training in neurology with an emphasis in epilepsy at the University of Miami College of Medicine in Miami, Florida. Nemire completed a Doctorate in Education with a major in Higher Education Leadership at the Nova Southeastern University Fischler School of Education. She has served as a Senior Vice President of the American Association of Colleges of Pharmacy and was the Founding Dean of the Fairleigh Dickinson School of Pharmacy. She founded ASK Education Inc a K-12 competency-based education Company. She serves in a leadership role for the Site Accreditation and Standards Institute, Inc. She has served in leadership and faculty roles for Schools of Medicine and Colleges of Pharmacy across the United States.

Her passions, professional and research expertise include leading and innovating, neurology, technology platforms for education, K-12 education on health, quality management, clinical research, and improving public health. She has disseminated information from research outcomes Nationally and Internationally at conferences, in textbooks, peer reviewed journals and in digital media. Nemire is co-editor of the Pharmacy Student Survival Guide. Her record of community service includes increasing immunization rates in underserved communities, disaster relief both nationally and internationally, and leadership in medical missions. Dr. Nemire is a Fellow of the American College of Clinical Pharmacy and the National Academies of Practice.

Dr. Haidar is currently Clinical Pharmacogenomics Senior Program Manager at St. Jude Children’s’ Research Hospital and Assistant Professor at The University of Tennessee Health Sciences Center, Department of Clinical Pharmacy and Translational Science. She received her Pharm.D. from the Lebanese American University, completed a Pharmacotherapy PGY1 at Hackensack University Medical Center, and Pediatric Oncology PGY2 Residency at St. Jude Children’s Research Hospital. Her practice is focused on Clinical Pharmacogenomics and its application in oncology. She is a founding member of the Pharmacogenomics Research Network (PGRN), and the Chair of the Pharmacogenomics Subcommittee of the Children’s Oncology Group (COG). Previous activities include serving on the Council on Therapeutics of the American Society of Health-System Pharmacists (ASHP), and serving two terms (including Chair) on the Council for Oncology for BPS. She is a contributing editor for pharmacogenomics of the American Journal of Health-System Pharmacy.

Dr. Ivey’s experience includes serving as vice president, Pharmacy Services for the Health Alliance of Greater Cincinnati, an integrated health care system. She is professor emerita in the Division of Pharmacy Practice and Administrative Sciences, College of Pharmacy at the University of Cincinnati. Her practice, research, and teaching expertise are in patient care delivery, automation, clinical outcomes, pharmacy resident training, leadership and pharmacy resource management in hospitals and integrated health systems. She chaired the University Hospital total quality improvement steering committee and served on the Health Alliance Six Sigma Steering Committee.

Dr. Ivey has served as ASHP president, chairman of the HOD, member of the Commission on Goals and the Commission on Credentialing and served as treasurer of ASHP and the ASHP Foundation. She received the Pharmacy Practice Award from the Federation of International Pharmaceutique (FIP) in September of 2011. She was President of the Hospital Pharmacy Section of FIP and serves on the Leadership Degree Advisory Board for the University of Cincinnati College of Pharmacy, the External Advisory Board of the University of Kentucky School of Pharmacy and the St. Louis College of Pharmacy President’s Advisory Council. Dr. Ivey has a B.S. from the University of Wisconsin. She received her Pharm.D. and M.P.H. from the University of Washington. She also completed the Wharton School’s hospital pharmacy executives program. Dr. Ivey is a Vice President of FIP and currently provides education and consulting in the areas of healthcare leadership and advocacy, safe medication management, post-doctoral training development and resource management and she now resides in Seattle, Washington.

Dr. Botts is the Regional Administrator of Clinical Pharmacy Services at Kaiser Permanente, Colorado, Clinical Associate Professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, and Co-Director of the joint KP-CU Pharmacy Research Fellowship. While at Kaiser Permanente, she has supported efforts to implement regional measurement-based care programs for depression and population monitoring gaps, assessment of medication adherence programs, integration of clinical pharmacy technicians, and dissemination of pharmacy best practices. Prior to Kaiser Permanente, she served on the faculty of the University of Kentucky, College of Pharmacy where she developed and directed the ASHP accredited residency training program in Psychiatric Pharmacy at the Lexington VA Medical Center. She has served on the CPNP Board of Directors and President as well as the CPNP Foundation Board.

Dr. Botts completed her B.S. in Chemistry at Centre College in Danville, Kentucky and her PharmD at the University of Kentucky. She completed a specialty residency and 2-year clinical sciences research fellowship at the University of Texas Health Sciences Center at San Antonio and San Antonio State Hospital. She recently completed the Kaiser Permanente Strategic Leadership Program as well as the Academy for Excellence in Healthcare, Operational Excellence program, provided by The Ohio State University Fisher College of Business & Cardinal Health.

Dr. Clancy serves as the Assistant Under Secretary for Health (AUSH) for Discovery, Education & Affiliate Networks (DEAN), Veterans Health Administration (VHA), effective July 22, 2018.

Prior to her current position, she served as the VHA Executive in Charge, with the authority to perform the functions and duties of the Under Secretary for Health. Previously, she served as the Interim Under Secretary for Health from 2014-2015. Dr. Clancy also served as the VHA AUSH for Organizational Excellence, overseeing VHA’s performance, quality, safety, risk management, systems engineering, auditing, oversight, ethics and accreditation programs, as well as ten years as the Director, Agency for Healthcare Research and Quality.

Dr. Clancy is a general internist and health services researcher, a graduate of Boston College and the University of Massachusetts Medical School. She holds an academic appointment at George Washington University’s School of Medicine and serves as Senior Associate Editor, Health Services Research Journal. She served as member of the National Quality Forum’s Board of Directors, Chair of the AQA Alliance and served on the Board of Governors for the Patient-Centered Outcomes Research Institute. She is an elected member of the National Academy of Medicine and was presented with the 2014 Quality Champion Award from the National Committee for Quality Assurance. She was also named as an Honorary Fellow of the American Academy of Nursing and was selected as the 2015 Outstanding Federal Executive of the Year by Disabled American Veterans. In 2018, she was selected as one of the Top 50 Physician Executives by Modern Healthcare, and in 2019, she was identified as one of the 50 Most Influential Clinical Executives by Modern Healthcare.

Dr. Divine is a Clinical Professor and Director of External Studies at the University of Kentucky (UK) College of Pharmacy. She is a 2015 recipient of the UK Provost’s Outstanding Teaching Award and a 2010 recipient of the American Pharmacists Association (APhA) Community Pharmacy Residency Excellence in Precepting Award.

Dr. Divine has practiced in ambulatory care for over 20 years and currently serves as a clinical pharmacist at Bluegrass Community Health Center in Lexington, KY. Previously, she was the co-founder of PharmacistCARE℠, a recipient of the 2008 American Society of Health-System Pharmacists Best Practices Award and 2005 APhA Foundation Pinnacle Award. Additionally, she was the founding Residency Program Director for UK’s PGY1 Community-Based Pharmacy Residency Program.

Ms. Gordon is a highly experienced executive leader with expertise in health policy and communications, organizational development, and stakeholder engagement in the public and private healthcare sectors. She runs a communications consultancy that specializes in writing, editing and stakeholder engagement/alliance development in the health and medical space. Previously, Ms. Gordon was CEO of the Institute for Advanced Clinical Trials (I-ACT) for Children, where she served for three years. Prior to joining I-ACT for Children, she was General Manager of the Health, Federal Government Services, Employee Engagement and Multicultural Engagement sectors for the Washington office of Edelman, a global communications agency where she spent a total of 22 years. Ms. Gordon received her BA in journalism from Kent State University.

Kowalski is a senior lecturer in clinical pharmacy at the University of South Australia and directs the University of South Australia’s post-graduate clinical pharmacy programs. He received his Bachelor of Pharmacy and Masters of Applied Science in Pharmacy from the South Australian Institute of Technology. His main clinical and research interests are in the fields of clinical pharmacy practice, neurological and geriatric pharmacotherapy.

Dr. Michnich served as Senior Scholar at the National Academy of Medicine prior to her retirement. Until September 2017 she served as the Senior Director of Health Policy Education Programs and Fellowships for the National Academy of Medicine (NAM) at the National Academies of Sciences, Engineering and Medicine. In that role, she advised the Robert Wood Johnson Foundation Health Policy Fellows, the NAM Anniversary Fellows, the Food and Drug Administration Tobacco Regulatory Science Fellows, and the Distinguished Nurse Scholar-in-Residence. During a leave of absence from the Academies in 2007, Michnich served as the Executive Director of the President’s Commission on Care for America’s Returning Wounded Warriors, Co-chaired by Senator Robert Dole and Secretary Donna Shalala. The Commission presented a landmark report to the President recommending fundamental changes to the disability determination and compensation systems of the DoD and VA, and expansion and improvement of coordination of benefits and services for service members and their families. Prior to her position at the NAM, Michnich served as a Senior Executive for both the Health Policy and the Clinical Practice and Scientific Services Divisions of the American College of Cardiology.

She has served on several Boards including the American Pharmacists Association Foundation, the National Center for Healthcare Leadership, and Providence Hospital in Washington, DC, where she also Chaired the Quality and Patient Safety Committee. She was selected as one of 15 Disruptive Women to Watch in 2015 and is the recipient of Civitas Award from the American Academy of Nursing as well as the Secretary of Defense Award for Outstanding Leadership.

She currently serves as a Health Care District Commissioner on Orcas Island, Washington.

Dr. Richards serves as the Clinical Pharmacy Specialist in Critical Care Medicine at St. Joseph’s Candler Health System in Savannah, Georgia, where he has been Program Director for the PGY-2 residency in Critical Care Medicine since 2011. Dr. Richards also has a faculty appointment with The University of Georgia College of Pharmacy as Clinical Assistant Professor. He received his BS in Pharmacy degree and PharmD from The University of Georgia College of Pharmacy. He completed a PGY-2 residency in Nutrition Support/Critical Care from The University of Arizona. Dr. Richards recently finished service as Chair of the BPS Critical Care Specialty Council where he was also an initial Council member and a member of the initial role delineation study for the BPS Critical Care Specialty.

Dr. Siu is a Clinical Professor and Director of Faculty Mentoring at the Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey. She practices at the K. Hovnanian Children’s Hospital at Jersey Shore University Medical Center, Member of the Hackensack Meridian Health System. She implemented therapeutic guidelines in neonates/pediatrics and is an advocate for pediatric medication safety and contributes to the literature with her research. She earned her BS and Pharm.D. plus completed her residency training at Philadelphia College of Pharmacy. She served two terms as Chair of the Specialty Council for Pediatric Pharmacy for BPS.

Dr. Yee is Associate Vice Chancellor for Academic Affairs and Professor of Pharmacy Practice and Science at the University of Nebraska Medical Center. He was previously a board certified oncology pharmacy specialist. He completed his B.S. in Pharmacy at the University of Washington, his Pharm.D. at the Philadelphia College of Pharmacy and Science, and post-doctoral training at St. Jude Children’s Research Hospital. His research findings have been published in the New England Journal of Medicine and the Lancet. He is one of the editors of Pharmacotherapy: A Pathophysiologic Approach. He is a Past President of the American College of Clinical Pharmacy.